Irish Health Service Covers Vertex’s Cystic Fibrosis Therapies Orkambi and Kalydeco
Cystic Fibrosis, News
Hundreds of cystic fibrosis patients in Ireland have obtained national health service coverage for the Vertex Pharmaceuticals therapies Orkambi (lumacaftor/ivacaftor) and Kalydeco (ivacaftor). The agreement between the Irish Health Service Executive and Vertex ... Read more